FI901195A0 - Lääkkeen vapautumista kontrolloiva koostumus - Google Patents

Lääkkeen vapautumista kontrolloiva koostumus

Info

Publication number
FI901195A0
FI901195A0 FI901195A FI901195A FI901195A0 FI 901195 A0 FI901195 A0 FI 901195A0 FI 901195 A FI901195 A FI 901195A FI 901195 A FI901195 A FI 901195A FI 901195 A0 FI901195 A0 FI 901195A0
Authority
FI
Finland
Prior art keywords
drug
coating material
long acting
drug release
composition
Prior art date
Application number
FI901195A
Other languages
English (en)
Swedish (sv)
Other versions
FI97690C (fi
FI97690B (fi
Inventor
Tadayoshi Ohmura
Muneo Fukui
Hiroshi Sugiura
Satoru Yoneya
Toshiharu Hosono
Atsushi Kajiyama
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of FI901195A0 publication Critical patent/FI901195A0/fi
Priority to FI951606A priority Critical patent/FI951606A/fi
Application granted granted Critical
Publication of FI97690B publication Critical patent/FI97690B/fi
Publication of FI97690C publication Critical patent/FI97690C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
FI901195A 1989-03-10 1990-03-09 Lääkkeen vapautumista kontrolloiva koostumus FI97690C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI951606A FI951606A (fi) 1989-03-10 1995-04-05 Keksinnön kohteena on menetelmä valmistaa pitkäaikaisvaikutteista rakeista farmaseuttista valmistetta

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5868489 1989-03-10
JP5868489 1989-03-10

Publications (3)

Publication Number Publication Date
FI901195A0 true FI901195A0 (fi) 1990-03-09
FI97690B FI97690B (fi) 1996-10-31
FI97690C FI97690C (fi) 1997-02-10

Family

ID=13091382

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901195A FI97690C (fi) 1989-03-10 1990-03-09 Lääkkeen vapautumista kontrolloiva koostumus

Country Status (19)

Country Link
US (1) US5028664A (fi)
EP (1) EP0386967B1 (fi)
JP (1) JPH037238A (fi)
KR (1) KR0140985B1 (fi)
CN (1) CN1045524A (fi)
AT (1) ATE124864T1 (fi)
AU (1) AU623233B2 (fi)
CA (1) CA2011919A1 (fi)
DD (2) DD298205A5 (fi)
DE (1) DE69020758T2 (fi)
DK (1) DK0386967T3 (fi)
ES (1) ES2077023T3 (fi)
FI (1) FI97690C (fi)
GR (1) GR3017645T3 (fi)
HU (1) HU204201B (fi)
IE (1) IE68520B1 (fi)
NO (1) NO301578B1 (fi)
NZ (1) NZ232836A (fi)
PT (1) PT93384B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP19971086B (en) * 1991-02-22 1997-12-02 Tillotts Pharma Ag Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US20030170290A1 (en) * 1993-06-16 2003-09-11 Shug Austin L. Delayed release carnitine
WO1995005168A1 (en) * 1993-08-19 1995-02-23 Shug Austin L Delayed release carnitine
DE9414066U1 (de) * 1994-08-31 1994-11-03 Roehm Gmbh Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
NZ270078A (en) * 1994-12-06 1998-05-27 Bernard Charles Sherman Diltiazem hydrochloride formulation comprising beads with immediate, intermediate, and delayed release dissolution profiles
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
WO1997004782A1 (fr) * 1995-07-26 1997-02-13 Kyowa Hakko Kogyo Co., Ltd. Dispersion solide ou preparation a dispersion solide de derives xanthine
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
US6303144B1 (en) 1998-02-10 2001-10-16 Welfide Corporation Preparations with controlled release
ATE367153T1 (de) * 1999-05-20 2007-08-15 Elan Corp Plc Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
NZ517465A (en) * 1999-09-02 2003-10-31 Nostrum Pharmaceuticals Inc Controlled release pellet formulation
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
WO2002066004A1 (fr) * 2001-02-23 2002-08-29 Mitsubishi Pharma Corporation Compositions a liberation controlee de medicament
UA76256C2 (en) * 2001-11-21 2006-07-17 Eisai Co Ltd Composition containing acid-unstable physiologically active compound and process for its preparation
NZ555693A (en) 2004-12-27 2010-10-29 Eisai R&D Man Co Ltd Matrix type sustained-release preparation containing donepezil
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
CN100398122C (zh) * 2005-01-28 2008-07-02 北京北大药业有限公司 一种治疗颈、腰椎病中药的肠溶包衣组合物
CN101888832A (zh) * 2008-01-10 2010-11-17 赢创罗姆有限公司 加快的活性物质受控释放的包衣药物或包衣营养制剂
EP2227225B1 (en) 2008-01-10 2018-11-14 Evonik Röhm GmbH Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
US9408393B2 (en) 2010-02-03 2016-08-09 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
JP5674684B2 (ja) 2009-02-03 2015-02-25 マイクロビオン コーポレーション 上皮組織、急性および慢性創傷、細菌性バイオフィルムならびに他の適応症のための消毒剤としてのビスマス−チオール
CN112804878A (zh) 2018-07-31 2021-05-14 微生物公司 铋-硫醇组合物和使用方法
EP3829299A4 (en) 2018-07-31 2022-04-13 Microbion Corporation BISMUTH THIOL COMPOSITIONS AND METHODS OF TREATMENT OF WOUNDS
WO2022029938A1 (ja) * 2020-08-05 2022-02-10 マルホ株式会社 皮膚用組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236914A (en) * 1959-05-12 1966-02-22 Canadian Ind Method for rendering polymers compatible
US3300429A (en) * 1963-06-17 1967-01-24 Rohm & Haas Aqueous polymeric blends containing ureido monomer
US3369009A (en) * 1964-12-10 1968-02-13 Hercules Inc Azidoformate-containing copolymers
US3641237A (en) * 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
US4065523A (en) * 1975-11-24 1977-12-27 Rohm And Haas Company Process for increasing molecular weight of a polymer
US4082705A (en) * 1976-02-05 1978-04-04 Johnson & Johnson Pressure sensitive adhesive compositions
GB2046275A (en) * 1979-03-27 1980-11-12 American Cyanamid Co Granulation and drying aids for polymeric gels
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
US4539199A (en) * 1981-01-14 1985-09-03 Egyt Gyogyszervegyeszeti Gyar Sustained release pharmaceutical compositions
US4758437A (en) * 1981-12-23 1988-07-19 Yamanouchi Pharmaceutical Co., Ltd. Composition for long acting nicardipine preparation and process of producing the composition
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
JPS60240747A (ja) * 1984-05-15 1985-11-29 Showa Denko Kk 架橋性組成物及びエステル架橋型重合体
JPS62126122A (ja) * 1985-11-27 1987-06-08 Showa Shinyaku Kk 表面コ−テイングされたイブプロフエン顆粒の製法
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
JP2667162B2 (ja) * 1986-11-04 1997-10-27 日本製紙株式会社 インクジエツト記録用シート
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat

Also Published As

Publication number Publication date
EP0386967B1 (en) 1995-07-12
EP0386967A3 (en) 1991-04-03
ATE124864T1 (de) 1995-07-15
NO901116D0 (no) 1990-03-09
US5028664A (en) 1991-07-02
NO901116L (no) 1990-09-11
HU901380D0 (en) 1990-05-28
FI97690C (fi) 1997-02-10
AU5122790A (en) 1990-09-13
IE68520B1 (en) 1996-06-26
CN1045524A (zh) 1990-09-26
EP0386967A2 (en) 1990-09-12
DE69020758T2 (de) 1995-12-07
PT93384B (pt) 1996-03-29
KR900013943A (ko) 1990-10-22
PT93384A (pt) 1990-11-07
ES2077023T3 (es) 1995-11-16
GR3017645T3 (en) 1996-01-31
IE900862L (en) 1990-09-10
NZ232836A (en) 1991-06-25
HUT53813A (en) 1990-12-28
FI97690B (fi) 1996-10-31
DK0386967T3 (da) 1995-11-20
DD292374A5 (de) 1991-08-01
NO301578B1 (no) 1997-11-17
DD298205A5 (de) 1992-02-13
AU623233B2 (en) 1992-05-07
DE69020758D1 (de) 1995-08-17
HU204201B (en) 1991-12-30
CA2011919A1 (en) 1990-09-10
KR0140985B1 (ko) 1998-06-01
JPH037238A (ja) 1991-01-14

Similar Documents

Publication Publication Date Title
FI97690B (fi) Lääkkeen vapautumista kontrolloiva koostumus
EP0396425A3 (en) Extended release pharmaceutical formulations
ATE123649T1 (de) Feste pharmazeutische retardform.
ATE222487T1 (de) Brausemittel und dessen herstellung
CA2037101A1 (en) Omeprazole Compositions Designed for Administration in Rectum
DK0868910T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater som bindemidler til fremstilling af faste farmaceutiske dispergeringsformer
CA2312710A1 (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
CA2105575A1 (en) Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
DK0923934T3 (da) Modified release-matrixformulering af cefaclor og cephalexin
DE69901487T2 (de) Eine didemnin verbindung enthaltende pharmazeutische formulierung
AU7125991A (en) Novel antiulcer substance
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
AU4737989A (en) Benzene derivatives, their preparation and pharmaceutical compositions in which they are present
DE69602886D1 (de) Im kardiovaskulären System aktive seco-D-Steroide und diese enthaltende pharmazeutische Zubereitungen
DE69016592T2 (de) 4-Amidino-Chroman und 4-Amidino-Pyrano(3,2-c)pyridinderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
GEP20012518B (en) Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine
DE3787319D1 (de) 1,4-Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
AU5766790A (en) Liquid polymer composition, and method of use

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: YAMANOUCHI PHARMACEUTICAL CO., LTD.